ArticlePloS one2025
Inhibition of Fusarium oxysporum growth in banana by silver nanoparticles: In vitro and in vivo assays.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Sustainable antifungal potential of ZnO and MoSWorld journal of microbiology & biotechnology · 2025Article
- Review
- The role of silver nanoparticles in yellow lupine (Lupinus luteus L.) defense response to Fusarium oxysporum f.sp. lupini.Scientific reports · 2025Article
- Effects of silver nanoparticles on the physiology, stress, and mineral uptake of banana cultivarsFrontiers in plant science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fusarium wilt is a devastating disease that affects banana crops worldwide. In Ecuador, bananas are one of the most important commodities and staple food. Nanoparticles are emerging as innovative solutions to control fungal diseases in plant protection. In this study, in vitro and in vivo assays were carried out to validate Fusarium oxysporum growth and disease inhibition. 96-well plates experiments were used to calculate the IC50 of three different silver nanoparticle formulations (Argovit-1220, Argovit-1221, and Argovit-C) against four Ecuadorian Fusarium strains race 1 (EC15-E-GM1, EC19-LR-GM3, EC35-G-GM6, EC40-M-GM2). More than 95% inhibition rate was obtained at 25 mg L-1 concentration. Fusarium wilt in vivo assay (greenhouse conditions) was carried out with Gros Michel plants, where better control was obtained by applying silver nanoparticles to the roots, reducing disease development by an average of 68%. This study shows that silver nanoparticles have a high antifungal potential for controlling the Fusarium wilt of bananas. To our knowledge, this is the first study to test the potential of AgNPs against Fusarium oxysporum race 1 in vitro and in vivo under greenhouse conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.